Showing results (101-110 of 172) with videos related to
Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2003
Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphomaJohn P Leonard, Morton Coleman, Jamie C Ketas, et al.Blood|September 9, 2006
Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRILApril Chiu, Weifeng Xu, Bing He, et al.JCO Global Oncology|July 8, 2020
Challenges of HIV Lymphoma Clinical Trials in Africa: Lessons From the AIDS Malignancy Consortium 068 StudyRobert M Strother, Satish Gopal, Meg Wirth, et al.Current Problems in Cancer. Case Reports|March 16, 2026
Breast-implant associated unicentric castleman disease: a case reportSaishravan Shyamsundar, Mateo Sarmiento Bustamante, Larissa Borys, et al.JAMA Network Open|March 22, 2021
Association of Age With SARS-CoV-2 Antibody ResponseHe S Yang, Victoria Costa, Sabrina E Racine-Brzostek, et al.Iscience|June 9, 2025
Locus-specific human endogenous retroviruses reveal lymphoma subtypesBhavya Singh, Nicholas Dopkins, Tongyi Fei, et al.Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
TOP-Plus is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody DurabilitySabrina E Racine-Brzostek, Mohsen Karbaschi, Christian Gaebler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.Biorxiv : the Preprint Server for Biology|June 19, 2023
Locus specific human endogenous retroviruses reveal new lymphoma subtypesBhavya Singh, Nicholas Dopkins, Tongyi Fei, et al.Blood|January 29, 2021
ROR1 targeting with the antibody-drug conjugate VLS-101 is effective in Richter syndrome patient-derived xenograft mouse modelsTiziana Vaisitti, Francesca Arruga, Nicoletta Vitale, et al.Pageof 18